DK0555446T3 - Anvendelse af antagonister eller partielle agonister ved 5-HT1a-receptoren til behandling og forebyggelse af kognitive fors - Google Patents

Anvendelse af antagonister eller partielle agonister ved 5-HT1a-receptoren til behandling og forebyggelse af kognitive fors

Info

Publication number: DK0555446T3
Authority: DK; Denmark
Prior art keywords: antagonists; prevention; treatment; partial agonists; ht1a receptor
Prior art date: 1991-08-31

Application number

DK92918251T

Other languages

Danish (da)

English (en)

Inventor

Jonathan Turner

Belinda Cole

Original Assignee

Bayer Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-08-31

Filing date

1992-08-28

Publication date

2000-01-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6443608&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0555446(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1992-08-28 Application filed by Bayer Ag filed Critical Bayer Ag

2000-01-31 Application granted granted Critical

2000-01-31 Publication of DK0555446T3 publication Critical patent/DK0555446T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK92918251T 1991-08-31 1992-08-28 Anvendelse af antagonister eller partielle agonister ved 5-HT1a-receptoren til behandling og forebyggelse af kognitive fors DK0555446T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE4135551A DE4135551A1 (de)	1991-08-31	1991-08-31	Verwendung von antagonisten oder partiellen agonisten am 5-ht1a-rezeptor zur behandlung und praevention von kognitiven stoerungen
PCT/DE1992/000720 WO1993004681A1 (fr)	1991-08-31	1992-08-28	UTILISATION D'ANTAGONISTES OU D'AGONISTES PARTIELS SUR UN RECEPTEUR 5-HT1a POUR LE TRAITEMENT ET LA PREVENTION DE TROUBLES COGNITIFS

Publications (1)

Publication Number	Publication Date
DK0555446T3 true DK0555446T3 (da)	2000-01-31

Family

ID=6443608

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK92918251T DK0555446T3 (da)	1991-08-31	1992-08-28	Anvendelse af antagonister eller partielle agonister ved 5-HT1a-receptoren til behandling og forebyggelse af kognitive fors

Country Status (10)

Country	Link
EP (1)	EP0555446B1 (fr)
JP (1)	JPH06501713A (fr)
AT (1)	ATE182467T1 (fr)
CA (1)	CA2093009A1 (fr)
DE (2)	DE4135551A1 (fr)
DK (1)	DK0555446T3 (fr)
ES (1)	ES2135412T3 (fr)
GR (1)	GR3031514T3 (fr)
HU (1)	HUT63331A (fr)
WO (1)	WO1993004681A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9223153D0 (en) *	1992-11-05	1992-12-16	Wyeth John & Brother Ltd	Piperazine derivatives
US5484788A (en) *	1993-03-26	1996-01-16	Beth Israel Hospital Association	Buspirone as a systemic immunosuppressant
EP0710481A1 (fr) *	1994-11-02	1996-05-08	Duphar International Research B.V	Emploi du flesinoxan comme stimulateur de la cognition
US5637314A (en) *	1995-06-07	1997-06-10	Beth Israel Deaconess Medical Center, Inc.	Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
EP1075486A1 (fr)	1998-05-06	2001-02-14	Duke University	Methode de traitement des affections du bas appareil urinaire et de la vessie
US7053092B2 (en)	2001-01-29	2006-05-30	Otsuka Pharmaceutical Co., Ltd.	5-HT1a receptor subtype agonist
US8703772B2 (en)	2001-09-25	2014-04-22	Otsuka Pharmaceutical Co., Ltd.	Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
AR033485A1 (es)	2001-09-25	2003-12-26	Otsuka Pharma Co Ltd	Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
GT200600416A (es)	2005-09-12	2007-09-20		Sales salicilato y gentisato de un compuesto de piperazina
GT200600414A (es)	2005-09-12	2007-09-20		Sal de glucuranato de compuesto de piperazine
PE20070523A1 (es)	2005-09-12	2007-06-28	Wyeth Corp	Formulacion de liberacion sostenida del glucuronato de (8-{4-[3-(5-fluoro-1h-indol-3-il)-propil]-piperazin-1-il}-2-metil-4h-benzo[1,4]oxazin-3-ona
WO2011150183A1 (fr)	2010-05-28	2011-12-01	Ge Healthcare Limited	Composés radiomarqués et leurs procédés
GB201112987D0 (en)	2011-07-28	2011-09-14	Ge Healthcare Ltd	Novel compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2355502A1 (fr) *	1976-06-23	1978-01-20	Roussel Uclaf	Application a titre de medicaments d'un derive de la piperazine et de ses sels
US4423049A (en) *	1981-12-28	1983-12-27	Mead Johnson & Company	2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines
US4897399A (en) *	1988-04-20	1990-01-30	Ciba-Geigy Corp.	Heterotertracyclic lactam derivatives, pharmaceutical compositions, and method of treating impaired memory and learning
GB2222768B (en) *	1988-06-17	1992-01-22	Nat Res Dev	Analgesic compounds and compositions
US4902687A (en) *	1989-03-27	1990-02-20	Eli Lilly And Company	Excitatory amino acid receptor antagonists
DE4039631A1 (de) *	1990-12-12	1992-06-17	Troponwerke Gmbh & Co Kg	Neuroprotektive kombination

1991
- 1991-08-31 DE DE4135551A patent/DE4135551A1/de not_active Withdrawn
1992
- 1992-08-28 CA CA002093009A patent/CA2093009A1/fr not_active Abandoned
- 1992-08-28 ES ES92918251T patent/ES2135412T3/es not_active Expired - Lifetime
- 1992-08-28 EP EP92918251A patent/EP0555446B1/fr not_active Revoked
- 1992-08-28 AT AT92918251T patent/ATE182467T1/de not_active IP Right Cessation
- 1992-08-28 DK DK92918251T patent/DK0555446T3/da active
- 1992-08-28 WO PCT/DE1992/000720 patent/WO1993004681A1/fr not_active Ceased
- 1992-08-28 HU HU9301250A patent/HUT63331A/hu unknown
- 1992-08-28 JP JP5504830A patent/JPH06501713A/ja active Pending
- 1992-08-28 DE DE59209728T patent/DE59209728D1/de not_active Revoked
1999
- 1999-10-13 GR GR990402609T patent/GR3031514T3/el unknown

Also Published As

Publication number	Publication date
HU9301250D0 (en)	1993-07-28
ES2135412T3 (es)	1999-11-01
GR3031514T3 (en)	2000-01-31
WO1993004681A1 (fr)	1993-03-18
CA2093009A1 (fr)	1993-03-01
EP0555446B1 (fr)	1999-07-28
ATE182467T1 (de)	1999-08-15
DE4135551A1 (de)	1993-03-04
JPH06501713A (ja)	1994-02-24
EP0555446A1 (fr)	1993-08-18
DE59209728D1 (de)	1999-09-02
HUT63331A (en)	1993-08-30

Similar Documents

Publication	Publication Date	Title
DK0555446T3 (da)	2000-01-31	Anvendelse af antagonister eller partielle agonister ved 5-HT1a-receptoren til behandling og forebyggelse af kognitive fors
AR219565A1 (es)	1980-08-29	Procedimiento para la preparacion de compuestos de 4-(di-n-propil)amino-1,3,4,5-tetrahidrobenc(c1d)indol y sus sales
NO180538C (no)	1997-05-07	N-sulfonyl-2-oksoindol-derivater som har affinitet for vasopressin- og/eller ocytocin-reseptorer, farmasöytiske blandinger som inneholder dem og mellomprodukter ved fremstilling av derivatene
CY2123B1 (en)	2002-06-21	Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides drugs containing these compounds and use of such drugs
MX9102501A (es)	1992-09-01	Derivados de metano sulfonamida, composiciones farderivados de metanosulfonamida, composiciones farmaceuticas que los contienen y procedimiento para smaceuticas que los contienen y procedimiento para u preparacion. su preparacion.
DK0687251T3 (da)	2002-06-03	1,3-dihydroindol-2-on-derivater, der er substitueret i 3-stillingen med en nitrogengruppe, til anvendelse som vasopressin- og/eller ocytocin-agonister og/eller -antagonister
NO943347L (no)	1994-11-09	Halichondriner og beslektede forbindelser
DK0506539T3 (da)	1997-12-01	heterocykliske alkylamider, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK0726899T3 (da)	2000-06-26	Nye pyrazincarboxamidderivater, deres fremstilling og deres anvendelse i lægemidler
MX9203505A (es)	1992-07-01	N-aril-n-(4-(1-alquilheterociclico)-piperidinil) amidas y composicines farmaceuticas y metodos que emplean dichos compuestos.
DK0639275T3 (da)	1998-04-14	Hidtil ukendte GABAa-receptorundertyper og fremgangsmåder til screening af lægemiddelforbindelser under anvendelse af imidazoquinoxaliner og pyrrolopyimidiner til binding til GABAa-receptorundertyper
NO157135C (no)	1988-01-27	Fremgangsmaate til termisk spalting av 1,2-dikloretan.
SE9003248L (sv)	1991-04-28	Anordning foer att vaenda foeremaal, t ex i samband med avsyning av desamma
MX9202656A (es)	1993-01-01	Compuestos de tiadiazabiciclooctano o tiadiazabicicloocteno, procedimiento para su obtencion y composicion herbicida que los contiene.
DE69606777D1 (de)	2000-03-30	Naphthamidderivate von 3-beta-amino azabicyclooctan oder nonan als antipsychotische arzneimittel
NO883986L (no)	1989-03-09	Fremgangsmaate for fremstilling av n-(substituert alkyliden)-1,2,3,4-tetrahydro-9-akridinaminer og anvendelse derav som medikamenter.
DK359887A (da)	1988-01-12	Termohaerdnende materialer indeholdende acryl-polymere, som er praktisk taget fri for aeaktive hydrogengrupperae
AR244690A1 (es)	1993-11-30	Compuestos con grupos triazol,tetrahidrofurano y fenilo,composicion fungicida que los contiene,procedimiento de preparacion de dichos compuestos y compuestos intermedios utilizados en los mismos.
ES2000369A6 (es)	1988-02-16	Un procedimiento para preparar di-t-butilfenoles sustituidos
DK165689C (da)	1993-06-01	1,5-disubstituerede imidazolderivater, fremgangsmaade til fremstilling af saadanne forbindelser, fungicidt praeparat indeholdende saadanne forbindelser samt anvendelse af saadanne forbindelser som fungicider
FI875538A7 (fi)	1988-06-18	Uudet maleimideihin perustuvat yhdisteet ja uudet, niitä sisältävät valolla kovettuvat koostumukset.
NO910991L (no)	1991-03-13	Fremgangsmaate og apparat som benyttes for omdanning av problemavfall til ufarlig aggregat.
DK204891D0 (da)	1991-12-20	Hidtil ukendte cyanoalkylbenzamidderivater, fremgangsmaade til fremstilling deraf, samt anvendelse af saadanne cyanoalkylbenzamidderivater som mellemprodukt ved fremstilling af substituerede n-(imidazolinyl-methyl)-benzamider
DK363685D0 (da)	1985-08-09	Katalysatorsammensaetning og anvendelse heraf til fremstilling af hydrogenholdige forbindelser
NO885406L (no)	1989-06-08	Fremgangsmaate for fremstilling av 4-heteroaryl-1,3-benzodiazepiner og 2-substituerte-alfa-(hetero-aryl)benzenetanaminer og anvendelse derav som medikamenter.